MedTrace Logo

Colombian Surgical Outcomes Study - COLSOS

NCT05147623 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1353

Last updated 2021-12-07

No results posted yet for this study

Summary

An observational, analytical, multicentre prospective cohort study will be conducted throughout Colombia. A sample size of 1353 patients is needed to achieve significance in our primary objective; however, convenience sampling is considered, as we aim to include all the institutions and patients possible. The data collection will be carried out prospectively for one week, and all patients will have a follow-up of a maximum of 30 days in-hospital. The primary outcome will be to determine the in-hospital mortality. We aim to contribute with accurate information on in-hospital postoperative mortality in Colombia. Thus, by following precisely the instructions created by The Lancet Commission on Global Surgery. The data obtained will help formulate public policies in the surgical field adjusted to the Colombian population, improving the quality of the surgical divisions in the different Colombian institutions, positively affecting the attention and development of the Colombian healthcare system.

Conditions

  • Surgery
  • Postoperative Complications
  • Hospital Mortality

Interventions

PROCEDURE

Any surgery/procedure

Any surgery/procedure in all adult patients that were performed in an operating room

Sponsors & Collaborators

  • Universidad del Rosario

    collaborator OTHER

  • Fundación Cardioinfantil Instituto de Cardiología

    lead OTHER

Principal Investigators

  • Paulo A. Cabrera, MD, MSc · Fundación Cardioinfantil Instituto de Cardiología

  • Carlos J. Perez, MD, MSc · Fundación Cardioinfantil Instituto de Cardiología

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-16
Primary Completion
2022-05-16
Completion
2023-05-22

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05147623 on ClinicalTrials.gov